Pioneering Cancer Treatments through Enhanced Genomic Profiling

News - Pioneering Cancer Treatments through Enhanced Genomic Profiling in the GenomeMET Project

22 February 2024
NML collaborate to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing

News - The National Measurement Laboratory and UK NEQAS for Leucocyte Immunophenotyping announce collaboration to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing

25 January 2024
LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning

News - LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning. This groundbreaking product rapidly delivers high-purity DNA in high-yields, typically achieving results in 5 minutes 

15 January 2024
LGC mid-year Update: 1 April – 30 September 2023

News - LGC announces half year trading results

15 December 2023
LGC acquires PolyDesign

News - LGC acquires PolyDesign, a provider of innovative oligo solid support products for life sciences customers.   

14 November 2023
National Measurement Laboratory at LGC supports the UK global leadership in ensuring accurate diagnostics for future pandemics.

News - National Measurement Laboratory at LGC supports the UK global leadership in ensuring accurate diagnostics for future pandemics.  

02 November 2023
LGC acquires Virusys Corporation.

News - LGC Clinical Diagnostics, a business unit of LGC, today announced the acquisition of Virusys Corporation, a developer and manufacturer of monoclonal antibodies and viral antigens.

09 October 2023
LGC Group appoints David King as Non-Executive Director and Chairman

News - LGC announced today the appointment of David P. King as Non-Executive Chairman of its Board of Directors.

28 September 2023
Review of methods and challenges associated with detection of Precision Bred Products

News - The UK National Reference Laboratory for GMOs based at LGC has reviewed the current state-of-the-art methods for the potential detection of Precision Bred Organisms (PBOs) in food and feed supply chains and to provide recommendations towards developing a framework for the traceability of PBOs.

18 September 2023
LGC acquires Kova International, Inc., including Biochemical Diagnostics, Inc., strengthening its portfolio of Quality Measurement Tools

News - Today, LGC Clinical Diagnostics, a business unit of LGC, announced the acquisition of Kova International, Inc. (Kova), a leading developer and manufacturer of in vitro urinalysis and toxicology quality control products for clinical laboratories

24 July 2023